GB8429087D0
(en)
*
|
1984-11-16 |
1984-12-27 |
Scras |
Thienopyridine derivatives
|
FR2576901B1
(fr)
*
|
1985-01-31 |
1987-03-20 |
Sanofi Sa |
Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
|
FR2596392B1
(fr)
*
|
1986-03-27 |
1988-08-05 |
Sanofi Sa |
Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
FR2597102B1
(fr)
*
|
1986-04-14 |
1988-08-26 |
Sanofi Sa |
Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
|
FR2623810B2
(fr)
*
|
1987-02-17 |
1992-01-24 |
Sanofi Sa |
Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
|
FR2612929B1
(fr)
*
|
1987-02-17 |
1990-02-09 |
Sanofi Sa |
Enantiomere dextrogyre de 1a-(tetrahydro- 4,5,6,7 thieno (3,2-c) pyridyl-5) (chloro-2 phenyl)-acetate de methyle, son procede de preparation et les compositions pharmaceutiques le renfermant
|
JPH0339159A
(ja)
*
|
1989-07-07 |
1991-02-20 |
Toichi Chikuma |
健康用具
|
FR2652575B1
(fr)
*
|
1989-09-29 |
1992-01-24 |
Sanofi Sa |
Procede de preparation d'acides alpha-bromo phenylacetiques.
|
US5189170A
(en)
*
|
1989-09-29 |
1993-02-23 |
Sanofi |
Process for the preparation of phenylacetic derivatives of thieno-pyridines
|
JPH03242154A
(ja)
*
|
1990-02-17 |
1991-10-29 |
Toichi Chikuma |
健康用具
|
FR2664596B1
(fr)
*
|
1990-07-10 |
1994-06-10 |
Sanofi Sa |
Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
|
FR2672801B1
(fr)
*
|
1991-02-14 |
1995-03-03 |
Sanofi Sa |
Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
|
FI101150B
(fi)
*
|
1991-09-09 |
1998-04-30 |
Sankyo Co |
Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
|
NZ334389A
(en)
*
|
1996-08-28 |
2001-05-25 |
Ube Industries |
Cyclic amine derivatives
|
HU222283B1
(hu)
*
|
1997-05-13 |
2003-05-28 |
Sanofi-Synthelabo |
Eljárás tieno[3,2-c]piridin-származékok előállítására
|
HU225504B1
(en)
*
|
1997-05-13 |
2007-01-29 |
Sanofi Aventis |
Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
|
HU225503B1
(en)
|
1997-05-13 |
2007-01-29 |
Sanofi Aventis |
Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
|
FR2769313B1
(fr)
*
|
1997-10-06 |
2000-04-21 |
Sanofi Sa |
Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
|
KR100567950B1
(ko)
|
1998-02-27 |
2006-04-05 |
상꾜 가부시키가이샤 |
환상 아미노화합물
|
WO1999065500A1
(en)
|
1998-06-17 |
1999-12-23 |
Bristol-Myers Squibb Company |
Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
|
HU226421B1
(en)
*
|
1998-11-09 |
2008-12-29 |
Sanofi Aventis |
Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
|
KR100768034B1
(ko)
|
1999-03-17 |
2007-10-17 |
다이이찌 세이야꾸 가부시기가이샤 |
의약 조성물
|
MXPA03005770A
(es)
*
|
2000-12-25 |
2003-09-10 |
Sankyo Co |
Composiciones medicinales que contienen aspirina.
|
MXPA03006133A
(es)
*
|
2001-01-24 |
2004-05-04 |
Cadila Healthcare Ltd |
Proceso para preparar clopidogrel.
|
IN191030B
(pt)
|
2001-01-24 |
2003-09-13 |
Cadila Healthcare Ltd |
|
US6495691B1
(en)
|
2001-07-06 |
2002-12-17 |
Brantford Chemicals Inc. |
Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
|
CA2352520C
(en)
*
|
2001-07-06 |
2007-10-02 |
Brantford Chemicals Inc. |
Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
|
US6767913B2
(en)
|
2001-12-18 |
2004-07-27 |
Teva Pharmaceutical Industries Ltd. |
Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
|
US7074928B2
(en)
|
2002-01-11 |
2006-07-11 |
Teva Pharmaceutical Industries, Ltd. |
Polymorphs of clopidogrel hydrogensulfate
|
HUP0200438A3
(en)
*
|
2002-02-06 |
2003-10-28 |
Egis Gyogyszergyar Nyilvanosan |
Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
|
ITMI20020933A1
(it)
*
|
2002-05-03 |
2003-11-03 |
Danimite Dipharma S P A |
Procedimento per la sintesi di clopidogrel
|
US6800759B2
(en)
*
|
2002-08-02 |
2004-10-05 |
Teva Pharmaceutical Industries Ltd. |
Racemization and enantiomer separation of clopidogrel
|
IL166593A0
(en)
|
2002-08-02 |
2006-01-15 |
|
Racemization and enantiomer separation of clopidogrel
|
WO2004031143A2
(en)
*
|
2002-10-02 |
2004-04-15 |
Bristol-Myers Squibb Company |
Novel combination of a factor xa inhibitor and clopidogrel
|
US6812363B2
(en)
*
|
2002-10-15 |
2004-11-02 |
Usv Limited |
Racemization of optically active 2-substituted phenyl glycine esters
|
ITMI20022228A1
(it)
*
|
2002-10-21 |
2004-04-22 |
Dinamite Dipharma S P A |
Sali di clopidogrel con acidi alchil-solforici.
|
EP1606231A1
(en)
*
|
2003-02-03 |
2005-12-21 |
Nadkarni, Sunil Sadanand |
Process for preparation of clopidogrel, its salts and pharmaceutical compositions
|
DE10305984A1
(de)
*
|
2003-02-13 |
2004-09-02 |
Helm Ag |
Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
|
AU2003238664A1
(en)
|
2003-03-12 |
2004-09-30 |
Cadila Healthcare Limited |
Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
|
DK1618111T3
(en)
|
2003-04-25 |
2015-02-16 |
Cadila Healthcare Ltd |
Salts of clopidogrel and the process for preparing
|
DE10337773A1
(de)
*
|
2003-08-13 |
2005-03-24 |
Krka Tovarna Zdravil, D.D. |
Kristallisation von festen Formen von Clopidogrel-Additionssalzen
|
GB0321256D0
(en)
|
2003-09-11 |
2003-10-08 |
Generics Uk Ltd |
Novel crystalline compounds
|
CA2544443C
(en)
|
2003-11-03 |
2010-08-17 |
Cadila Healthcare Limited |
Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
|
CA2454015C
(en)
*
|
2003-12-23 |
2009-11-24 |
Brantford Chemicals Inc. |
A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
|
CA2457459A1
(en)
*
|
2004-02-11 |
2005-08-11 |
Brantford Chemicals Inc. |
Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
|
EP1750701A1
(en)
*
|
2004-06-01 |
2007-02-14 |
IVAX Pharmaceuticals s.r.o. |
Amorphous clopidogrel hydrochloride and its antithrombotic use
|
AR050631A1
(es)
*
|
2004-09-09 |
2006-11-08 |
Novartis Ag |
Combinacion de compuestos organicos
|
EP1704152A2
(en)
*
|
2004-09-21 |
2006-09-27 |
Teva Pharmaceutical Industries Ltd |
Crystalline clopidogrel hydrobromide and processes for preparation thereof
|
WO2006091847A2
(en)
*
|
2005-02-24 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
|
CZ299213B6
(cs)
|
2005-03-08 |
2008-05-21 |
Zentiva, A. S |
Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové
|
WO2006130852A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Dr. Reddy's Laboratories Ltd. |
Recovery of clopidogrel bisulfate
|
US8063217B2
(en)
*
|
2005-07-12 |
2011-11-22 |
Rpg Life Sciences Limited |
Process for preparation of methyl-(+)-(S)-alpha-(2-chlorophenyl)-6, 7-dihydrothieno[3,2-C]pyridine-5(4H) -acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
|
WO2007029080A1
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Preparation of form i of clopidogrel hydrochloride
|
US7994322B2
(en)
*
|
2005-09-05 |
2011-08-09 |
Cadila Healthcare Limited |
Processes for the preparation of different forms of (S)-(+)-clopidogrel besylate
|
WO2007029096A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Novel polymorphic forms of clopidogrel hydrochloride
|
CN100390180C
(zh)
*
|
2005-12-15 |
2008-05-28 |
上海应用技术学院 |
氯吡格雷及其盐的制备方法
|
KR101235117B1
(ko)
*
|
2005-12-26 |
2013-02-20 |
에스케이케미칼주식회사 |
광학분리에 의한 (s)-(+)-클로피도그렐의 제조방법
|
KR100742134B1
(ko)
*
|
2006-02-07 |
2007-07-24 |
경동제약 주식회사 |
결정성S-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-c]피리딘-5(4H)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
|
TR201816133T4
(tr)
|
2006-04-04 |
2018-11-21 |
Kg Acquisition Llc |
Bi̇r anti̇platelet ajan ve bi̇r asi̇t i̇nhi̇bi̇törü i̇çeren oral dozaj formlari.
|
CN102014899A
(zh)
*
|
2006-04-27 |
2011-04-13 |
因-斯韦特实验室有限公司 |
硫酸氢氯吡格雷多晶型物的制备方法
|
EP2064217B1
(en)
*
|
2006-09-04 |
2011-01-19 |
Ranbaxy Laboratories Limited |
An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
|
EP1900358A1
(en)
|
2006-09-16 |
2008-03-19 |
Cimex Pharma AG |
Pharmaceutical formulations comprising clopidogrel
|
US20100062066A1
(en)
*
|
2006-11-14 |
2010-03-11 |
Acusphere, Inc |
Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
|
EP1980563A1
(en)
|
2007-04-09 |
2008-10-15 |
BATTULA, Srinivasa Reddy |
Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
|
EP2084164A2
(en)
*
|
2007-04-18 |
2009-08-05 |
Teva Pharmaceutical Industries Ltd. |
Improved process for preparing clopidogrel
|
HUE053158T2
(hu)
|
2007-04-27 |
2021-06-28 |
Cydex Pharmaceuticals Inc |
Clopidogrelt és szulfoalkiléter ciklodextrint tartalmazó készítmények és alkalmazási eljárások
|
WO2008146249A1
(en)
*
|
2007-05-30 |
2008-12-04 |
Wockhardt Research Centre |
Processes for the preparation of clopidogrel
|
WO2009080469A1
(en)
*
|
2007-12-24 |
2009-07-02 |
Sandoz Ag |
Process for the preparation of clopidogrel bisulphate form i
|
EP2095815B1
(en)
*
|
2008-02-26 |
2011-10-26 |
Laboratorios Lesvi, S.L. |
Pharmaceutical formulations containing clopidogrel
|
JP5589838B2
(ja)
|
2008-04-01 |
2014-09-17 |
アステラス製薬株式会社 |
血管性疾患の予防剤及び/又は治療剤
|
EP2107061A1
(en)
|
2008-04-02 |
2009-10-07 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically enriched clopidogrel
|
US20090264460A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Mamta Mishra |
Clopidogrel pharmaceutical formulations
|
US9427448B2
(en)
|
2009-11-11 |
2016-08-30 |
The Medicines Company |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
WO2009140092A1
(en)
*
|
2008-05-13 |
2009-11-19 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
US20130303477A1
(en)
*
|
2008-05-13 |
2013-11-14 |
The Medicines Company |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
|
US8759316B2
(en)
*
|
2008-05-13 |
2014-06-24 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
US20120141468A1
(en)
*
|
2008-05-13 |
2012-06-07 |
Lisa Ruderman Chen |
Maintenance of platelet inhibition during antiplatelet therapy
|
KR100990949B1
(ko)
*
|
2008-06-09 |
2010-10-29 |
엔자이텍 주식회사 |
클로피도그렐 및 그의 유도체의 제조방법
|
US8299097B2
(en)
*
|
2008-09-12 |
2012-10-30 |
The Brigham And Women's Hospital, Inc. |
Methods for treating inflammatory disorders
|
EP2346879A1
(en)
*
|
2008-10-24 |
2011-07-27 |
Sandoz AG |
A process for the preparation of s-clopidogrel
|
US8563690B2
(en)
*
|
2008-11-03 |
2013-10-22 |
The Board Of Trustees Of The University Of Illinois |
Modulation of platelet aggregation
|
CN101402641B
(zh)
*
|
2008-11-20 |
2011-05-04 |
天津药物研究院 |
含噻吩并吡啶的肟类衍生物、其制备方法和用途
|
EP3061460A1
(en)
|
2009-04-10 |
2016-08-31 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
PL3100728T3
(pl)
|
2009-05-13 |
2020-05-18 |
Cydex Pharmaceuticals, Inc. |
Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
|
EP2445861B1
(en)
|
2009-06-25 |
2014-03-26 |
Tetra, Sia |
Novel acetylsalicylic acid salts
|
CN101585842B
(zh)
*
|
2009-07-13 |
2011-07-20 |
北京赛科药业有限责任公司 |
氯吡格雷中杂质b的研究及控制方法
|
AU2010319612B2
(en)
|
2009-11-11 |
2016-01-14 |
Chiesi Farmaceutici S.P.A. |
Methods of treating or preventing stent thrombosis
|
US10376532B2
(en)
|
2009-11-11 |
2019-08-13 |
Chiesi Farmaceutici, S.P.A. |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
WO2011101865A2
(en)
|
2010-02-19 |
2011-08-25 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of clopidogrel for parenteral delivery
|
CN102212069A
(zh)
*
|
2010-04-06 |
2011-10-12 |
刘桂坤 |
环烷衍生物及其制备方法和在心脑血管病药物上的应用
|
CN101812071A
(zh)
*
|
2010-05-10 |
2010-08-25 |
杭州和素化学技术有限公司 |
硫酸氢氯吡格雷中间体拆分后的母液处理方法
|
CN102241690B
(zh)
|
2010-05-13 |
2015-08-12 |
天津药物研究院 |
一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
|
CN101863901B
(zh)
*
|
2010-06-29 |
2012-12-05 |
天津药物研究院 |
2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途
|
WO2012007019A1
(en)
|
2010-07-13 |
2012-01-19 |
Pharmathen S.A. |
Process for the preparation of clopidogrel and salts thereof
|
KR20130101517A
(ko)
|
2010-08-26 |
2013-09-13 |
아이피시에이 래버러토리즈 리미티드 |
혈전증 또는 색전증의 치료 또는 예방 방법
|
CN101974015B
(zh)
*
|
2010-10-11 |
2012-05-09 |
天津药物研究院 |
酯类化合物、其制备方法和用途
|
CN101962388B
(zh)
*
|
2010-10-14 |
2012-12-19 |
天津药物研究院 |
乙酰胺衍生物及其制备方法和用途
|
CN101974016A
(zh)
*
|
2010-10-14 |
2011-02-16 |
天津药物研究院 |
酰胺类化合物及其制备方法和用途
|
MX337179B
(es)
|
2010-10-18 |
2016-02-15 |
Cerenis Therapeutics Holding Sa |
Compuestos, composiciones y metodos utiles para la movilizacion de colesterol.
|
WO2012123958A1
(en)
|
2011-02-14 |
2012-09-20 |
Cadila Healthcare Limited |
Highly pure salts of clopidogrel free of genotoxic impurities
|
AU2012277327B2
(en)
|
2011-06-27 |
2017-04-27 |
Ipca Laboratories Limited |
Anti-thrombotic compounds
|
US9539246B2
(en)
|
2011-08-30 |
2017-01-10 |
University Of Utah Research Foundation |
Methods and compositions for treating nephrogenic diabetes insipidus
|
CA2858522A1
(en)
|
2011-12-09 |
2013-06-13 |
Wockhardt Limited |
Methods for treating cardiovascular disorder
|
CN103665042B
(zh)
*
|
2012-09-21 |
2016-03-16 |
北京普禄德医药科技有限公司 |
光学活性的2-羟基四氢噻吩并吡啶衍生物及其制备方法和用途
|
CN102993210A
(zh)
*
|
2012-12-19 |
2013-03-27 |
苏春华 |
一种吡啶并噻吩的新化合物
|
WO2014118802A1
(en)
|
2013-01-31 |
2014-08-07 |
Pharmazell Gmbh |
An improved process for the preparation of clopidogrel bisulfate form-i
|
CN104447867B
(zh)
*
|
2013-09-17 |
2017-12-26 |
江苏天士力帝益药业有限公司 |
一种噻吩并哌啶衍生物、制备方法及其应用
|
DE102014108210A1
(de)
*
|
2014-06-11 |
2015-12-17 |
Dietrich Gulba |
Rodentizid
|
HUP1400294A2
(hu)
|
2014-06-13 |
2015-12-28 |
Skillpharm Kft |
Clopidogrel új alkalmazása
|
CN107698620A
(zh)
|
2015-06-23 |
2018-02-16 |
江苏天士力帝益药业有限公司 |
一种氘代噻吩并哌啶衍生物、制备方法及其应用
|
WO2018234565A1
(en)
|
2017-06-23 |
2018-12-27 |
Chiesi Farmaceutici S.P.A. |
METHOD FOR PREVENTING SHUNT THROMBOSIS FROM THE SYSTEMIC-PULMONARY ARTERY
|
EP4070658A1
(de)
|
2021-04-06 |
2022-10-12 |
BIORoxx GmbH |
Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
|
US20230059869A1
(en)
|
2021-08-03 |
2023-02-23 |
Liqmeds Worldwide Limited |
Oral pharmaceutical solution of clopidogrel
|
CN115260086A
(zh)
*
|
2022-09-28 |
2022-11-01 |
吉林大学 |
一种氟代内标物及其应用和制备方法
|